Niki BioSolutions, Inc 20-F for FY2020

Headline figures

Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net income

$6.31M

compared with a net loss of $18.69M a year earlier

Diluted EPS

$0.20

compared with -$0.64 a year earlier